HMD
Click for more information
0.00% 2.1¢ heramed limited

Ann: HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device, page-6

  1. Alby118
    1,071 Posts.
    lightbulb Created with Sketch. 179
    clock Created with Sketch.
    18/11/19
    09:21
    Post #: 41477203
    Receiving the 510(k) clearance for the HeraBEAT US device now allows that product to be commercially distributed throughout the United States. HeraMED will progress the device’s entry into the US market, as quickly as practicable.

    bagger today.
    the giant will wake up. this will be in over $1 on horizon.
    Last edited by Alby118: 18/11/19
    HMD Price at posting: 21.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS A$17 Million Cash Sale of Citadel Joint Venture Interest
right-arrow Created with Sketch.
NEWS Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat
right-arrow Created with Sketch.
NEWS First paediatric clinical site activated – major recruitment milestone and key appointment announced
right-arrow Created with Sketch.
NEWS Resource skyrockets 80% to 91Moz AgEq – exceptional grades and more drilling to come
right-arrow Created with Sketch.
LU7 Discover the world of North American lithium chemicals with the "Dream Team"
right-arrow Created with Sketch.
NEWS PLS: HotCopper's Most Discussed Stock of The Week!
right-arrow Created with Sketch.
watchlist Created with Sketch. Add HMD (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.29M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $3.437K 163.6K

Buyers (Bids)

No. Vol. Price($)
2 261809 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 200000 1
View Market Depth
Last trade - 15.00pm 13/09/2024 (20 minute delay) ?
HMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.